CESAREAN DELIVERY
Clinical trials for CESAREAN DELIVERY explained in plain language.
Never miss a new study
Get alerted when new CESAREAN DELIVERY trials appear
Sign up with your email to follow new studies for CESAREAN DELIVERY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple drug make repeat C-Sections safer?
Disease control Not yet recruitingThis study tests whether giving tranexamic acid (TXA) after the baby is delivered can reduce blood loss during repeat cesarean sections in women at low risk for bleeding. About 204 women will be randomly assigned to receive TXA or a placebo. The goal is to see if TXA meaningfully…
Matched conditions: CESAREAN DELIVERY
Phase: NA • Sponsor: Ege University • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New drug could keep new moms Opioid-Free after C-Section
Symptom relief Not yet recruitingThis study tests whether a drug called suzetrigine can help women who have a C-section avoid taking opioid painkillers. About 90 women will receive either suzetrigine or a placebo along with standard pain relief. The main goal is to see how many stay completely opioid-free for th…
Matched conditions: CESAREAN DELIVERY
Phase: PHASE4 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated May 17, 2026 08:04 UTC
-
New study aims to ease tugging and pressure during C-Sections
Symptom relief Not yet recruitingThis study tests adding two drugs, dexmedetomidine or clonidine, to standard spinal anesthesia for women having a C-section. The goal is to reduce uncomfortable pulling, tugging, or pressure during surgery and improve pain relief after. About 150 pregnant women will take part, an…
Matched conditions: CESAREAN DELIVERY
Phase: PHASE4 • Sponsor: Columbia University • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
C-Section bleeding breakthrough? new study tests topical TXA
Symptom relief Not yet recruitingThis study tests if applying tranexamic acid (TXA) directly to the uterus during a planned C-section can reduce surgical bleeding. About 112 women having their first or second C-section will be randomly assigned to receive either TXA or a placebo. The main goal is to see if TXA s…
Matched conditions: CESAREAN DELIVERY
Phase: EARLY_PHASE1 • Sponsor: Wolfson Medical Center • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC